Louis Portugal to Treatment Outcome
This is a "connection" page, showing publications Louis Portugal has written about Treatment Outcome.
Connection Strength
0.065
-
Salvage treatment for recurrent squamous cell carcinoma of the oral cavity. Head Neck. 2000 Jan; 22(1):34-41.
Score: 0.019
-
Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies. Head Neck Oncol. 2011 Jul 26; 3:31.
Score: 0.010
-
Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation. Cancer. 2011 Oct 15; 117(20):4671-8.
Score: 0.010
-
Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck. 2004 May; 26(5):447-55.
Score: 0.006
-
Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer. Clin Cancer Res. 2003 May; 9(5):1689-97.
Score: 0.006
-
Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer. J Clin Oncol. 2003 Jan 15; 21(2):320-6.
Score: 0.006
-
Well-differentiated thyroid carcinomas: p53 mutation status and microvessel density. Head Neck. 1998 Mar; 20(2):152-8.
Score: 0.004
-
Prognostic indicators for squamous cell carcinoma of the oral cavity: a clinicopathologic correlation. Laryngoscope. 1997 Sep; 107(9):1239-44.
Score: 0.004